The TNF-α level in the peripheral blood mononuclear cell supernatants of patients with inflammatory bowel disease (IBD) is elevated, and the presence of TRPA1 antagonists abolishes the inflammatory effects of TNF-α (Campaniello et al., 2017). Here, TNF is linked to inflammatory bowel disease.